MDM2-p53 antagonists trigger cell death more efficiently than DNA damaging drugs and cooperatively with them in MNA NB cells, since they very efficiently engage the proapoptotic power of the HIPK2/p53 pathway by inducing HIPK2, in this cell type [13]. The gene discussed is HIPK2; the disease is neuroblastoma.